Cargando…

Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience

BACKGROUND: Induction therapy is used in about 80% of lung transplant centers and is increasing globally. Currently, there are no standards or guidelines for the use of induction therapy. At our institution, we have two induction strategies, basiliximab, and alemtuzumab. The goal of this manuscript...

Descripción completa

Detalles Bibliográficos
Autores principales:	Furukawa, Masashi, Chan, Ernest G., Ryan, John P., Hyzny, Eric J., Sacha, Lauren M., Coster, Jenalee N., Pilewski, Joseph M., Lendermon, Elizabeth A., Kilaru, Silpa D., McDyer, John F., Sanchez, Pablo G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199390/ https://www.ncbi.nlm.nih.gov/pubmed/35720296 http://dx.doi.org/10.3389/fimmu.2022.864545

Ejemplares similares

Immediate Postoperative COVID-19 Infection after Lung Transplantation: A Systematic Review and Case Series
por: Donohue, Jack K., et al.
Publicado: (2023)

Sequential redo-bilateral lung transplantation in recipient with prior heart-lung transplantation with tracheal anastomosis
por: Coster, Jenalee N., et al.
Publicado: (2023)

Lymphocytes as an Indicator for Initial Kidney Function: A Single Center Analysis of Outcome after Alemtuzumab or Basiliximab Induction
por: Weissenbacher, Annemarie, et al.
Publicado: (2015)

Experience using a flexible reinforced fiber suture for sternal closure in bilateral lung transplantation recipients undergoing bilateral transverse thoracosternotomy
por: Coster, Jenalee N., et al.
Publicado: (2022)

Thymoglobulin Versus Alemtuzumab Versus Basiliximab Kidney Transplantation From Donors After Circulatory Death
por: Asderakis, Argiris, et al.
Publicado: (2022)

Modulation of tissue resident memory T cells by glucocorticoids after acute cellular rejection in lung transplantation
por: Snyder, Mark E., et al.
Publicado: (2022)

Hyperbaric oxygen therapy for extensive bronchial necrosis and dehiscence after lung transplantation
por: Furukawa, Masashi, et al.
Publicado: (2023)

Lung Transplantation Outcomes in Recipients Aged 70 Years or Older and the Impact of Center Volume
por: Iyanna, Nidhi, et al.
Publicado: (2023)

Efficacy of basiliximab induction in poorly matched living donor renal transplantation
por: Gundlapalli, S., et al.
Publicado: (2013)

Reduced Progression of Cardiac Allograft Vasculopathy with Routine Use of Induction Therapy with Basiliximab
por: Wang, Ricardo, et al.
Publicado: (2015)

Basiliximab Induction with Delayed Calcineurin Inhibitors for High-Risk Lung Transplant Candidates
por: Kim, Ha Eun, et al.
Publicado: (2021)

Azithromycin decreases NALP3 mRNA stability in monocytes to limit inflammasome-dependent inflammation
por: Lendermon, Elizabeth A., et al.
Publicado: (2017)

Alemtuzumab induction in pediatric kidney transplantation
por: Kaabak, Michael M, et al.
Publicado: (2013)

Alemtuzumab induction therapy in solid organ transplantation
por: Friend, Peter J
Publicado: (2013)

Basiliximab induction therapy in kidney transplantation: Benefits for long term allograft function after 10 years?
por: Koch, Martina, et al.
Publicado: (2009)

Comparison of Basiliximab and Anti‐Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival Analysis
por: Ansari, David, et al.
Publicado: (2015)

The role of basiliximab in the evolving renal transplantation immunosuppression protocol
por: Salis, Paola, et al.
Publicado: (2008)

Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study
por: Lam, Ngan N., et al.
Publicado: (2021)

Standard induction with basiliximab versus no induction in low immunological risk kidney transplant recipients: study protocol for a randomized controlled trial
por: Ajlan, Aziza, et al.
Publicado: (2021)

Alemtuzumab
por: Tridente, Giuseppe
Publicado: (2013)

Antithymocyte globulin versus basiliximab induction for kidney transplantation in elderly patients: matched analysis within the Korean multicentric registry
por: Lee, Jun Young, et al.
Publicado: (2022)

Extracorporeal life support during lung transplantation
por: Coster, Jenalee Nicole, et al.
Publicado: (2021)

Impact of Induction Immunosuppressants on T Lymphocyte Subsets after Kidney Transplantation: A Prospective Observational Study with Focus on Anti-Thymocyte Globulin and Basiliximab Induction Therapies
por: Kim, Hyung Duk, et al.
Publicado: (2023)

Commentary: Everybody hurts, sometimes: ERAS against opioids
por: Coster, Jenalee N., et al.
Publicado: (2020)

Alemtuzumab in chronic lymphocytic leukemia
por: Fraser, G., et al.
Publicado: (2007)

Basiliximab/steroids/tacrolimus: Pneumonia with Scedosporium apiospermum and Lomentospora prolificans: case report
Publicado: (2021)

Steroid Sparing Maintenance Immunosuppression in Highly Sensitised Patients Receiving Alemtuzumab Induction
por: Santos, Eva, et al.
Publicado: (2023)

Alemtuzumab for Multiple Sclerosis
por: Willis, Mark D., et al.
Publicado: (2016)

Alemtuzumab in Covid era
por: Iovino, Aniello, et al.
Publicado: (2021)

Jejuno-jejunal intussusception in a post-lung transplant patient from a gastrojejunostomy tube: A case report
por: Harano, Takashi, et al.
Publicado: (2019)

Long-term efficacy of alemtuzumab in polymyositis
por: Ruck, Tobias, et al.
Publicado: (2015)

Differential expression of circulating miRNAs after alemtuzumab induction therapy in lung transplantation
por: Benazzo, A., et al.
Publicado: (2022)

CD4(+) T-Cell Dysfunction in Severe COVID-19 Disease Is Tumor Necrosis Factor-α/Tumor Necrosis Factor Receptor 1–Dependent
por: Popescu, Iulia, et al.
Publicado: (2022)

Alemtuzumab Induction and Delayed Acute Rejection in Steroid-Free Simultaneous Pancreas-Kidney Transplant Recipients
por: Bank, Jonna R., et al.
Publicado: (2016)

Anti-interleukin-2 receptor antibodies—basiliximab and daclizumab—for the prevention of acute rejection in renal transplantation
por: Sageshima, Junichiro, et al.
Publicado: (2009)

Treating a GAD65 Antibody-Associated Limbic Encephalitis with Basiliximab: A Case Study
por: Widman, Guido, et al.
Publicado: (2015)

Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients Treated With Both Basiliximab and Antithymocyte Globulin
por: Jeong, Rachel, et al.
Publicado: (2020)

Alemtuzumab in the up-front setting
por: Kaufman, Matthew, et al.
Publicado: (2008)

Alemtuzumab in the treatment of multiple sclerosis
por: Fernandez, Óscar
Publicado: (2014)

Alemtuzumab for the treatment of multiple sclerosis
por: Willis, Mark D, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rm92kc24l1prb5mnjcs2e8cggq